Diamant Asset Management, Inc.
Source: SEC Form 13F · as of Mar 2026Diamant Asset Management, Inc. holds 11 biotech & pharma companies tracked by BioSniper, totaling $14.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$14.9M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 4,473,008 | $4.5M |
| ABBVAbbVie Inc. | 3,671,231 | $3.7M |
| MRKMerck & Co., Inc. | 2,068,387 | $2.1M |
| LLYELI LILLY & Co | 1,070,612 | $1.1M |
| GEHCGE HealthCare Technologies Inc. | 797,216 | $797K |
| PMPhilip Morris International Inc | 710,962 | $711K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 569,592 | $570K |
| BBIOBridgeBio Pharma, Inc. | 527,246 | $527K |
| NVONovo Nordisk A/S | 401,310 | $401K |
| ZTSZoetis Inc. | 335,125 | $335K |
| CORCencora Inc. | 292,150 | $292K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.